New treatments

This page will list articles and news about new cancer treatments.

Quebec and New Brunswick Become First Provinces to Provide Public Funding of IBRANCE™ for the First-Line Treatment of Metastatic Breast Cancer

Health Canada Approves New Indication for ZYTIGA®* (abiraterone acetate), Broadening its Use for Treatment of Newly Diagnosed Metastatic Prostate Cancer

Health Canada approves Ipsen’s Somatuline® Autogel® for the treatment of carcinoid syndrome in adult patients with neuroendocrine tumours (NETs)

Tagrisso® (osimertinib) receives full Health Canada approval for targeted treatment of non-small cell lung cancer

Prix Galien Canada – Innovative Product Award Given to Merck Canada Inc. for Pembrolizumab (Keytruda)